Olema Pharmaceuticals Inc (OLMA)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-01-13 | 2025-01-08 | A Achat |
Bain Capital Life Sciences Investors, LLC Actionnaire important |
300 000
+4.0%
5,761 727 370 USD |
300 000 +4.0% | 5,76 | 1 727 370 USD | |
| 2024-12-17 | 2024-12-17 | V Vente | Administrateur non-exécutif |
700 761
-100.0%
6,754 730 137 USD |
700 761 -100.0% | 6,75 | 4 730 137 USD | |
| 2024-12-11 | 2024-12-11 | V Vente | Administrateur non-exécutif |
179
-0.0%
9,391 681 USD |
179 -0.0% | 9,39 | 1 681 USD | |
| 2024-12-11 | 2024-12-11 | V Vente | Administrateur non-exécutif |
7 958
-1.0%
8,6668 916 USD |
7 958 -1.0% | 8,66 | 68 916 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
CH. OPERATING & FINANCIAL OFF. Dirigeant |
406
-0.1%
9,393 812 USD |
406 -0.1% | 9,39 | 3 812 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
CH. OPERATING & FINANCIAL OFF. Dirigeant |
17 950
-3.2%
8,66155 447 USD |
17 950 -3.2% | 8,66 | 155 447 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
CH. DISCOV. & NON-CLIN DEV OFF Dirigeant |
300
-0.1%
9,392 817 USD |
300 -0.1% | 9,39 | 2 817 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
CH. DISCOV. & NON-CLIN DEV OFF Dirigeant |
13 314
-2.2%
8,66115 299 USD |
13 314 -2.2% | 8,66 | 115 299 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
PRESIDENT AND CEO Administrateur exécutif |
1 267
-0.5%
9,3911 897 USD |
1 267 -0.5% | 9,39 | 11 897 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
PRESIDENT AND CEO Administrateur exécutif |
55 907
-18.7%
8,66484 155 USD |
55 907 -18.7% | 8,66 | 484 155 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
320
-0.3%
9,393 005 USD |
320 -0.3% | 9,39 | 3 005 USD | |
| 2024-12-11 | 2024-12-11 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
14 202
-10.9%
8,66122 989 USD |
14 202 -10.9% | 8,66 | 122 989 USD | |
| 2024-12-11 | 2024-12-10 | V Vente | Administrateur non-exécutif |
8 256
-1.1%
9,3777 359 USD |
8 256 -1.1% | 9,37 | 77 359 USD | |
| 2024-12-11 | 2024-12-10 | V Vente |
CH. OPERATING & FINANCIAL OFF. Dirigeant |
16 803
-2.9%
9,37157 444 USD |
16 803 -2.9% | 9,37 | 157 444 USD | |
| 2024-12-11 | 2024-12-10 | V Vente |
CH. DISCOV. & NON-CLIN DEV OFF Dirigeant |
12 452
-2.0%
9,38116 800 USD |
12 452 -2.0% | 9,38 | 116 800 USD | |
| 2024-12-11 | 2024-12-10 | V Vente |
PRESIDENT AND CEO Administrateur exécutif |
52 328
-14.9%
9,37490 313 USD |
52 328 -14.9% | 9,37 | 490 313 USD | |
| 2024-12-11 | 2024-12-10 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
13 283
-9.3%
9,37124 462 USD |
13 283 -9.3% | 9,37 | 124 462 USD | |
| 2024-08-05 | 2024-08-01 | V Vente |
Paradigm Biocapital Advisors LP Actionnaire important |
529 501
-40.3%
14,927 897 507 USD |
529 501 -40.3% | 14,92 | 7 897 507 USD | |
| 2024-08-05 | 2024-08-01 | V Vente |
Paradigm Biocapital Advisors LP Actionnaire important |
1 870 499
-28.4%
14,9227 898 493 USD |
1 870 499 -28.4% | 14,92 | 27 898 493 USD | |
| 2024-07-31 | 2024-07-30 | VP Vente planifiée | Administrateur non-exécutif |
934
-0.1%
15,5514 524 USD |
934 -0.1% | 15,55 | 14 524 USD |